Abstract
Purpose
The purpose of this study was to examine gender- and age-specific prevalence, incidence, and the type of anti-asthma medications used in the Norwegian population aged 2–29 years during 2005–2007 and to estimate the share of individuals who regularly redeemed medications over a 3-year period.
Methods
We retrieved data from the nationwide Norwegian Prescription Database for all individuals 2–29 years old (n = 1.7 million) who received anti-asthma medications during 2005–2007. Medications included inhaled short- and long-acting β2-agonists, inhaled corticosteroids, fixed-dose combinations of inhaled β2-agonists and corticosteroids, and leukotriene antagonists.
Results
In 2007, 5.5% (92,074 individuals) of Norwegians aged 2–29 years received anti-asthma medication, and this figure was stable throughout 2005–2007. Prevalence and incidence were higher among males than females but shifted to female dominance during adolescence. The share of anti-asthma medication users who received inhaled corticosteroids was high in preschool children but decreased by age. Conversely, use of inhaled β2-agonists as monotherapy and of fixed combinations increased with age. Fewer than half the individuals were “persistent” to medication treatment for 3 years by redeeming prescriptions regularly (at least once a year).
Conclusions
In this nationwide study, annual prevalence of anti-asthma medication use was stable during 2005–2007. The gender- and age-specific profile of prevalence and incidence correspond well with other studies. Fewer than half the individuals redeemed prescriptions regularly over 3 years.
Similar content being viewed by others
References
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225–1232
Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, Standring P, Steriu A, Goulding R (2004) Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12–14 year olds in the British Isles, 1995–2002: questionnaire survey. Br Med J 328:1052–1053
von Hertzen L, Haahtela T (2005) Signs of reversing trends in prevalence of asthma. Allergy 60:283–292
Rees J (2005) ABC of asthma—Prevalence. Br Med J 331:443–445
Burney P (2002) The changing prevalence of asthma? Thorax 57:36–39
National Heart Lung and Blood Institute (NHLBI) (2007) Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma
Global Initiative for Asthma (GINA) (2007) Global strategy for asthma management and prevention
Furu K, Skurtveit S, Langhammer A, Nafstad P (2007) Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 63:693–698
Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)—new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 18:129–136
WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health (2008) Guidelines for ATC classification and DDD assignment. Norway, Oslo
Hågå A, Sverre JM (2002) Pricing and reimbursement of pharmaceuticals in Norway. Eur J Health Economics 3:215–220
Hallas J (2005) Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf 14:455–463
Caetano PA, Lam JM, Morgan SG (2006) Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 28:1411–1424
Mäkelä MJ, Virta L, Kaila M, Grönlund J, Vanto T, Klaukka T (2008) Medication use in children with asthma in Finland from 1995 to 2006. J Allergy Clin Immunol 122:648–649
Drazen JM, O’Byrne PM (2009) Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med 360:1671–1672
Nafstad P, Magnus P, Jaakkola JJK (2000) Early respiratory infections and childhood asthma. Pediatrics 106:e38
Nafstad P, Brunekreef B, Skrondal A, Nystad W (2005) Early respiratory infections, asthma, and allergy: 10-year follow-up of the Oslo Birth Cohort. Pediatrics 116:e255–e262
Selnes A, Nystad W, Bolle R, Lund E (2005) Diverging prevalence trends of atopic disorders in Norwegian children. Results from three cross-sectional studies. Allergy 60:894–899
Carlsen KCL, Haland G, Devulapalli CS, Munthe-Kaas M, Pettersen M, Granum B, Lovik M, Carlsen KH (2006) Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study*. Allergy 61:454–460
Tollefsen E, Bjermer L, Langhammer A, Johnsen R, Holmen TL (2006) Adolescent respiratory symptoms-girls are at risk: the Young-HUNT study, Norway. Respir Med 100:471–476
de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-Van den Berg LT (2006) The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. Eur J Clin Pharmacol 62:51–55
Osman M (2003) Therapeutic implications of sex differences in asthma and atopy. Arch Dis Child 88:587–590
Wright AL, Stern DA, Kauffmann F, Martinez FD (2006) Factors influencing gender differences in the diagnosis and treatment of asthma in childhood: the Tucson Children’s Respiratory Study. Pediatr Pulmonol 41:318–325
Almqvist C, Worm M, Leynaert B (2008) Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63:47–57
Rönmark E, Perzanowski M, Platts-Mills T, Lundback B (2002) Incidence rates and risk factors for asthma among school children: a 2-year follow-up report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 96:1006–1013
Kozyrskyj AL, Mustard CA, Becker AB (2004) Identifying children with persistent asthma from health care administrative records. Can Respir J 11:141–145
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, The Group (1995) Asthma and wheezing in the first six years of life. N Engl J Med 332:133–138
Stein RT, Martinez FD (2004) Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev 5:155–161
Pekkanen J, Sunyer J (2008) Problems in using incidence to analyze risk factors in follow-up studies. Eur J Epidemiol 23:581–584
Saglani S, Bush A (2009) Asthma in preschool children: the next challenge. Curr Opin Allergy Clinical Immunology 9:141–145
Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM (1993) Primary non-compliance with prescribed medication in primary care. Br Med J 307:846–848
Author information
Authors and Affiliations
Corresponding author
Additional information
Sources of funding
This work was funded by the Research Council of Norway.
Disclosure of potential conflict of interest
All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Karlstad, Ø., Nafstad, P., Tverdal, A. et al. Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study. Eur J Clin Pharmacol 66, 399–406 (2010). https://doi.org/10.1007/s00228-009-0749-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0749-x